Page last updated: 2024-09-02

kt 5823 and Cardiac Hypertrophy

kt 5823 has been researched along with Cardiac Hypertrophy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asada, Y; Hatakeyama, K; Imamura, T; Kitamura, K; Masuyama, H; Sekita, Y; Tsuruda, T1
Scholz, PM; Tan, T; Weiss, HR1
Davidov, T; Grover, GJ; Moalem, J; Scholz, PM; Weiss, HR; Zhang, Q1
Gong, G; Scholz, PM; Straznicka, M; Weiss, HR; Yan, L1
Engel, S; Scholz, P; Weiss, H; Yan, L1

Other Studies

5 other study(ies) available for kt 5823 and Cardiac Hypertrophy

ArticleYear
Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:4

    Topics: Animals; Animals, Newborn; Carbazoles; Cardiomegaly; Cell Hypoxia; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Down-Regulation; Enzyme Activation; Enzyme Activators; Guanylate Cyclase; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocytes, Cardiac; Neovascularization, Physiologic; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Time Factors; Vascular Endothelial Growth Factor A; Ventricular Remodeling

2009
Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
    Life sciences, 2010, Jul-03, Volume: 87, Issue:1-2

    Topics: Animals; Carbazoles; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Up-Regulation

2010
Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
    The Journal of surgical research, 2006, Volume: 135, Issue:1

    Topics: Animals; Carbazoles; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Guanylate Cyclase; Heart Ventricles; Hypertension, Renal; Hypertrophy; Indoles; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Protein Kinase Inhibitors; Rabbits; Signal Transduction; Surgical Instruments

2006
Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
    Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:2

    Topics: Alkaloids; Animals; Carbazoles; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Indoles; Myocardium; Oxygen Consumption; Purinones; Rabbits

1999
Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes.
    European journal of pharmacology, 2001, Jun-01, Volume: 421, Issue:1

    Topics: Alkaloids; Animals; Carbazoles; Cardiomegaly; Cell Size; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Ventricles; Indoles; Phosphorylation; Rabbits; Thyroxine

2001